Anna P. Matynia
No Rating Available
(Learn About Our Rating System)

Anna P. Matynia, MD

Languages spoken: English, Polish

Dr. Matynia is the Head of Clinical Operations for Solid Tumor Molecular Pathology at ARUP. She is also an associate professor at the University of Utah.

Specialties

  • Pathology, Clinical
  • Hematopathology
  • Pathology, Anatomical

Board Certification

American Board of Pathology (Anatomic & Clinical)
American Board of Pathology (Sub: Hematology)
American Board of Pathology (Sub: Molecular Genetic Pathology)

Dr. Matynia is the Head of Clinical Operations for Solid Tumor Molecular Pathology at ARUP. She is also an associate professor at the University of Utah.

Board Certification and Academic Information

Academic Departments Pathology -Associate Professor (Clinical)
Board Certification
American Board of Pathology (Anatomic & Clinical)
American Board of Pathology (Sub: Hematology)
American Board of Pathology (Sub: Molecular Genetic Pathology)

Education history

Professional Medical Medicine - Jagiellonian University M.D.
Internship University Hospital Transitional Internship
Residency Anatomic and Clinical Pathology - University of Utah/ARUP Laboratories Resident
Chief Resident Anatomic and Clinical Pathology - University of Utah/ARUP Laboratories Co-Chief Resident
Fellowship Hematopathology - University of Utah/ARUP Laboratories Fellow
Fellowship Molecular Genetic Pathology - University of Utah/ARUP Laboratories Fellow

Selected Publications

Journal Article

  1. Li P, Alnoor FNU, Xie W, Williams M, Feusier J, Ding Y, Zhao X, Zheng G, Zhao C, Zieske AW, Zu Y, Raess PW, Tantravahi S, Osman A, Patel AB, Tashi T, Patel JL, Matynia AP, Menon MP, Miles RR, Jacobsen JR, George TI, Sborov DW, Szankasi P, Rindler P, Close D, Ohgami R (2024). Rapid growth of acquired UBA1 mutations predisposes male patients to low-risk MDS. Leukemia, 39(1), 248-256.
  2. Wilcock DM, Schmidt RL, Furtado LV, Matynia AP, Deftereos G, Sirohi (2022). Histologic and Molecular Characterization of Non-Small Cell Lung Carcinoma With Discordant ROS1 Immunohistochemistry and Fluorescence In Situ Hybridization. Applied immunohistochemistry & molecular morphology, 30(1), 19-26.
  3. Deftereos G, Sandoval A, Furtado LV, Bronner M, Matynia A (2020). Successful lung cancer EGFR sequencing from DNA extracted from TTF-1 immunohistochemistry slides: a new means to extend insufficient tissue. Human pathology, 97, 52-59.
  4. Stewart RL, Matynia AP, Factor RE, Varley K (2020). Spatially-resolved quantification of proteins in triple negative breast cancers reveals differences in the immune microenvironment associated with prognosis. Scientific reports, 10(1), 6598.
  5. Matynia AP, Li KD, Szankasi P, Schumacher J, Liew M, Salama ME, Kelley T (2019). Molecular Fingerprinting of Anatomically and Temporally Distinct B-Cell Lymphoma Samples by Next-Generation Sequencing to Establish Clonal Relatedness. Archives of pathology & laboratory medicine, 143(1), 105-111.
  6. Matynia AP, Perkins SL, Li (2018). Lymphomatoid Granulomatosis in a 14-Year-Old Boy with Trisomy 21 and History of B-Lymphoblastic Leukemia/Lymphoma. Fetal and pediatric pathology, 37(1), 7-14.
  7. Schumacher JA, Scott Reading N, Szankasi P, Matynia AP, Kelley T (2015). A novel approach to quantitating leukemia fusion transcripts by qRT-PCR without the need for standard curves. Experimental and molecular pathology, 99(1), 104-8.

Case Report

  1. Jedrzkiewicz J, Quencer K, Matynia AP, Morrow E, Pletneva M, Barraza (2019). Peutz-Jeghers Type Polyp of the Appendix with Review of Literature. Case reports in pathology, 2019, 7584070.